InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
T+90 hit rate
94%
T+90 mean return
+19.6%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Struthers Richard Scott, Chairman & CEO. Insider active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Cumulatively, 26 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €4.1m. History available since 7 September 2021. The latest transaction was disclosed on 26 September 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations26 total
4,000 shares@ US$45.002.5% of flowCommon StockSEC:0001658247-25-000011:0
90,400 shares0Common StockSEC:0000950170-25-073605:0
81,270 shares@ US$1.912.3% of flowCommon StockSEC:0000950170-25-051170:0
16,463 shares@ US$34.178.3% of flowCommon StockSEC:0000950170-25-043401:0
89,000 shares0Common StockSEC:0000950170-25-025667:0
10,000 shares@ US$57.578.8% of flowCommon StockSEC:0000950170-24-133297:0
107,448 shares@ US$9.2814.9% of flowCommon StockSEC:0000950170-24-057926:0
350 shares0Common StockSEC:0000950170-24-046523:0
20,000 shares@ US$1.910.6% of flowCommon StockSEC:0000950170-24-045136:0
40,951 shares@ US$9.285.6% of flowCommon StockSEC:0000950170-24-042681:0
12,687 shares@ US$38.147.2% of flowCommon StockSEC:0001209191-24-005008:0
65,000 shares0Common StockSEC:0001209191-24-004608:0
60,000 shares0Common StockSEC:0001209191-24-003354:0
50,000 shares@ US$1.911.4% of flowCommon StockSEC:0001209191-23-055022:0
918 shares@ US$9.280.1% of flowCommon StockSEC:0001209191-23-054567:0
10,000 shares@ US$1.910.3% of flowCommon StockSEC:0001209191-23-046024:0
24,384 shares@ US$20.147.2% of flowCommon StockSEC:0001209191-23-042229:0
50,000 shares@ US$20.8115.3% of flowCommon StockSEC:0001209191-23-038851:0
4,628 shares@ US$17.121.2% of flowCommon StockSEC:0001209191-23-019772:0
61,650 shares0Common StockSEC:0001209191-23-015524:0
11,100 shares@ US$1.910.4% of flowCommon StockSEC:0001209191-22-053680:0
24,674 shares@ US$25.42470.013% mcap38.5% of flowCommon StockSEC:0001209191-22-024531:0
21,357 shares@ US$25.34180.011% mcap33.2% of flowCommon StockSEC:0001209191-22-023722:0
53,400 shares0Common StockSEC:0001209191-22-015134:0
10,000 shares@ US$25.000.0047% mcap14.1% of flowCommon stockSEC:0001209191-21-055312:0
25 of 26 declarations
About Struthers Richard Scott
Richard Scott Struthers is the Chief Executive Officer of Crinetics Pharmaceuticals, Inc. He leads the company with a focus on innovation in the pharmaceutical field. His leadership is essential for the development of new treatments and for the growth of Crinetics.
